ipriflavone has been researched along with Menopause in 5 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ipriflavone could inhibit bone resorption and promote bone formation." | 2.75 | Effects of ipriflavone on postmenopausal syndrome and osteoporosis. ( Dong, CL; Du, J; Li, SW; Wu, JF; Zhang, X; Zhang, YP; Zheng, CX, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, X | 1 |
| Li, SW | 1 |
| Wu, JF | 1 |
| Dong, CL | 1 |
| Zheng, CX | 1 |
| Zhang, YP | 1 |
| Du, J | 1 |
| Kang, HJ | 1 |
| Ansbacher, R | 1 |
| Hammoud, MM | 1 |
| Gambacciani, M | 1 |
| Cappagli, B | 1 |
| Piaggesi, L | 1 |
| Ciaponi, M | 1 |
| Genazzani, AR | 1 |
| Tsourounis, C | 1 |
| Katase, K | 1 |
| Kato, T | 1 |
| Hirai, Y | 1 |
| Hasumi, K | 1 |
| Chen, JT | 1 |
2 reviews available for ipriflavone and Menopause
| Article | Year |
|---|---|
Use of alternative and complementary medicine in menopause.
Topics: Angelica sinensis; Bone Density; Bone Remodeling; Cimicifuga; Complementary Therapies; Drugs, Chines | 2002 |
Clinical effects of phytoestrogens.
Topics: Bone Density; Breast Neoplasms; Cholesterol; Estrogens, Non-Steroidal; Female; Hormone Replacement T | 2001 |
3 trials available for ipriflavone and Menopause
| Article | Year |
|---|---|
Effects of ipriflavone on postmenopausal syndrome and osteoporosis.
Topics: Acid Phosphatase; Adult; Alanine Transaminase; Bone Density; Bone Remodeling; Calcium; Double-Blind | 2010 |
Ipriflavone prevents the loss of bone mass in pharmacological menopause induced by GnRH-agonists.
Topics: Absorptiometry, Photon; Analysis of Variance; Antineoplastic Agents, Hormonal; Bone Density; Bone Re | 1997 |
Effects of ipriflavone on bone loss following a bilateral ovariectomy and menopause: a randomized placebo-controlled study.
Topics: Bone Density; Bone Remodeling; Female; Humans; Isoflavones; Menopause; Middle Aged; Osteoporosis; Os | 2001 |